@article{10902/32239,
year = {2015},
url = {https://hdl.handle.net/10902/32239},
organization = {This study was supported by the Cooperative Research Thematic Network grants RD12/0036/0058 of the Red de Cancer (Cancer Network of Excellence); Instituto de Salud Carlos III, Spain, Instituto de Salud Carlos III/Subdirección General de Investigación Sanitaria (FIS: PI060339; 06/1354; 02/0905; 01/0089/01-02; PS09/01897/01370; G03/136; Sara Borrell: CD13/00340); and Asociación Española Contra el Cáncer (GCB120981SAN), Spain. The study was also supported internationally by the International Myeloma Foundation Junior Grant Proposal and the Multiple Myeloma Research Foundation research fellow award.},
publisher = {Ferrata Storti Foundation},
publisher = {Haematologica, 100(2), e53-55},
title = {The prognostic value of multiparameter flow cytometry minimal residual disease assessment in relapsed multiple myeloma},
author = {Paiva, Bruno and Chandia, Mauricio and Puig, Noemi and Vidriales, Maria-Belen and Perez, Jose J. and Lopez-Corra, Lucia and Ocio San Miguel, Enrique María and Garcia-Sanz, Ramon and Gutierrez, Norma C and Jimenez-Ubieto, Ana and Lahuerta, Juan-José and Mateos, Maria-Victoria},
}